Mesenchymal Stem Cell Therapy(Weston Brain Institute)

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameMesenchymal Stem Cell Therapy(Weston Brain Institute)

Drug Alias Nameautologous, adipose-derived, Mesenchymal Stem Cells (adMSCs)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsCognitive Dysfunction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesWeston Brain Institute

China Registration ClassN/A

Develop Information

Active CompaniesWeston Brain Institute

Inactive CompaniesN/A

Active IndicationsCognitive Dysfunction

Inactive IndicationsN/A

Other Information

ATC CodeN/A